Literature DB >> 8899423

Efficiency of orthotopic xenograft models for human colon cancers.

M Pocard1, H Tsukui, R J Salmon, B Dutrillaux, M F Poupon.   

Abstract

It is feasible to graft human colon cancer tissue into immuno-deficient nude mice, in order to maintain these tumors in vivo. Analysis of the properties tumors under such conditions might increase our knowledge of their biological characteristics. Xenografts are usually implanted into subcutaneous tissue, a site easily accessible for both graft procedure and observation of tumor growth. However these subcutaneous tumors are usually non-invasive and fail to metastasize. To override these limitations we, as others, have tried to improve the tumor xenograft model by transplanting tumors into their original location, designated as the orthotopic site. Transplanted into the cecum of nude mice, human colon cancers were frequently locally invasive and developed liver metastases. These transplantations may be done by injection of colon cancer cell suspensions into the cecal wall. Alternatively, orthotopic implantations of histologically intact tissue were performed and the thus-obtained tumors were more metastatic than tumors obtained after tumor cell injections. The chemosensibility of tumors xenografted into their orthotopic site was different from that of their subcutaneously implanted counterpart. This, added to the enhancement of invasive and metastatic properties, leads us to conclude that colon cancer xenografted into the caecum might be more representative of the clinical situation. We have reviewed the literature and report on the possibilities and limitations different models of colon cancer in vivo.

Entities:  

Mesh:

Year:  1996        PMID: 8899423

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  15 in total

1.  An orthotopic xenograft model with survival hindlimb amputation allows investigation of the effect of tumor microenvironment on sarcoma metastasis.

Authors:  Seth D Goldstein; Masanori Hayashi; Catherine M Albert; Kyle W Jackson; David M Loeb
Journal:  Clin Exp Metastasis       Date:  2015-08-18       Impact factor: 5.150

Review 2.  Mouse models in oncogenesis and cancer therapy.

Authors:  M V Céspedes; I Casanova; M Parreño; R Mangues
Journal:  Clin Transl Oncol       Date:  2006-05       Impact factor: 3.405

3.  Overview of human primary tumorgraft models: comparisons with traditional oncology preclinical models and the clinical relevance and utility of primary tumorgrafts in basic and translational oncology research.

Authors:  David H Lum; Cindy Matsen; Alana L Welm; Bryan E Welm
Journal:  Curr Protoc Pharmacol       Date:  2012-12

4.  Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.

Authors:  Roya Navab; Jiang Liu; Isolde Seiden-Long; Warren Shih; Ming Li; Bizhan Bandarchi; Yan Chen; Davina Lau; Yen-Fen Zu; Dave Cescon; Chang Qi Zhu; Shawna Organ; Emin Ibrahimov; Dina Ohanessian; Ming-Sound Tsao
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

5.  Targeted noninvasive imaging of EGFR-expressing orthotopic pancreatic cancer using multispectral optoacoustic tomography.

Authors:  Shanice V Hudson; Justin S Huang; Wenyuan Yin; Sabrin Albeituni; Jamie Rush; Anil Khanal; Jun Yan; Brian P Ceresa; Hermann B Frieboes; Lacey R McNally
Journal:  Cancer Res       Date:  2014-09-12       Impact factor: 12.701

6.  A simple colostomy implantation model for evaluating colon cancer.

Authors:  Heiying Jin; Xiufang Liu; Vicky Ka Ming Li; Yijiang Ding; Shifeng Yun; Fei Liu; Senmei Zhou; Yong Song; Min Ni
Journal:  Int J Colorectal Dis       Date:  2008-09-05       Impact factor: 2.571

7.  Animal models of human colorectal cancer: Current status, uses and limitations.

Authors:  Vijay K Mittal; Jasneet Singh Bhullar; Kumar Jayant
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

8.  The Establishment of a Fast and Safe Orthotopic Colon Cancer Model Using a Tissue Adhesive Technique.

Authors:  Hong-Tao Hu; Zhe Wang; Myung Ji Kim; Lu-Shang Jiang; Shi-Jun Xu; Jaeyun Jung; Eunji Lee; Jung-Hoon Park; Nader Bakheet; Sung Hwan Yoon; Kun Yung Kim; Ho-Young Song; Suhwan Chang
Journal:  Cancer Res Treat       Date:  2020-12-15       Impact factor: 4.679

9.  Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer Model.

Authors:  Jessica Kalra; Jennifer Baker; Justin Song; Alastair Kyle; Andrew Minchinton; Marcel Bally
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

10.  Antisense oligonucleotide against hTERT (Cantide) inhibits tumor growth in an orthotopic primary hepatic lymphoma mouse model.

Authors:  Bo Yang; Rui-li Yu; Shuai Tuo; Chao-wei Tuo; Qiu-zhen Liu; Ning Zhang; Xue-chun Lu; Xiao-hua Chi; Shu-bao Lv; Li-li Cai
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.